12.07.2015 Views

#06-5558 Accrd Manual V7 - COLA

#06-5558 Accrd Manual V7 - COLA

#06-5558 Accrd Manual V7 - COLA

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CRITERIA FOR QUALITY LABORATORY PERFORMANCE>VirologyVI 1 EIf you perform viral identification in your laboratory, do you document the use of uninoculated cells or cell substratecontrols cultured simultaneously with patients’ specimens as a negative control?VI 2 RIf you perform viral identifications, do you maintain host systems to cover the full range of isolates necessaryto identify the clinical diseases for which you are offering laboratory services?VI 3 RIf you perform viral testing, are records maintained that describe the systems used and the reactions observed?IMMUNOLOGYSyphilis SerologySY 1 EDo all the equipment, glassware, reagents, and techniques conform to manufacturer’s specifications?Check for the requirements in the package insert of the kit you are using.SY 2 RAre appropriately-sized cards used for testing?Again, check the package insert for the size circle card which must be used.SY 3 RIs the speed of the rotator monitored each day of use?Check the manufacturer’s package insert to determine the speed of rotation required for test performance(this is generally defined as # of rotations/minute). It is important to regulate the speed of the rotator as therotation has an effect on the antibody/antigen reaction. Too rapid a rate could break up the antibody/antigenreaction, resulting in a false negative. Too slow a rate may inhibit the antibody and antigen from reactingdue to lack of adequate contact. This may also result in a false negative result. Be sure to document thischeck each day of testing.SY 4 EIs the needle used for testing calibrated regularly?Follow the manufacturer’s recommendation and record when this is performed. The method for doing thisshould be included in the procedure for this test.SY 5 RAre positive and negative controls being used in the same manner as patient specimens to ensure reactivity anduniform dosages for all test phases?. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .FOR MORE INFORMATION CONTACT <strong>COLA</strong> PHONE 800.981.9883 | FAX 410.381.8611 | ON-LINE www.cola.org49

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!